Who Paid My Doc
Andre Kalil
Infectious Disease Omaha, NE Medical Doctor
NPI 1265480750 CMS profile 1111763
988102 Nebraska Medical Ctr, Omaha, NE 68198
General payments
$11,482
Research payments
$0
Ownership & investment interest
$0
Through program year 2025, Andre Kalil of Omaha, NE is reported in the CMS Open Payments database as having received $11,482 across 10 general payments and $0 in research payments paid to them.
No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.
General payments for this record sit in the 88th percentile of Infectious Disease profiles with reported payments. Percentile describes the distribution, not the conduct.
By program year
2 rows| Year | Kind | Relative to this record's peak year | Amount | Records |
|---|---|---|---|---|
| 2025 | General | $7,373 | 6 | |
| 2023 | General | $4,110 | 4 |
Beside peers
- Andre Kalil
- Infectious Disease median
- Middle half of Infectious Disease
- National median
In program year 2025, general payments to Andre Kalil were reported at $7,373. Among 3,905 Infectious Disease profiles paid that year, the median was $188 and the middle half received between $57 and $766.
Show as a table
| Year | Andre Kalil | Infectious Disease median | Middle half | National median |
|---|---|---|---|---|
| 2019 | $0 | $190 | $60–$862 | $163 |
| 2020 | $0 | $124 | $32–$606 | $114 |
| 2021 | $0 | $148 | $38–$905 | $132 |
| 2022 | $0 | $166 | $50–$834 | $149 |
| 2023 | $4,110 | $171 | $57–$787 | $160 |
| 2024 | $0 | $176 | $52–$752 | $164 |
| 2025 | $7,373 | $188 | $57–$766 | $169 |
Breakdown
Billing to Medicare
Part B · data year 2024 · 7 billing codesPaid by Medicare
$35,195
Medicare patients
80
Services billed
397
| Condition among their Medicare patients | Relative to the most common | Share of patients |
|---|---|---|
| High blood pressure | 75% | |
| Chronic kidney disease | 75% | |
| Diabetes | 65% | |
| Heart failure | 50% | |
| Ischemic heart disease | 49% | |
| Atrial fibrillation | 49% | |
| Depression | 49% | |
| Arthritis | 46% |
Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.
Records
10 reportedEvery payment, record by record
Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.
Other Infectious Disease in Nebraska
Related records
Infectious Disease in Nebraska
Practitioners in the same specialty and state, ranked by reported value.
All Infectious Disease
Everyone recorded under this specialty, nationwide.
Doctors in Nebraska
Every practitioner in the state with a reported payment.
How to read this page
What each amount means, and what it does not mean.
What this means
U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.
An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.
Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.